Third Pfizer dose 86% effective in over 60s, Israeli HMO says

A third dose of Pfizer (PFE.N)/BioNTech's (22UAy.DE) COVID-19 vaccine was found to be 86% effective in people aged over 60, an Israeli healthcare provider said on Wednesday, citing initial results from a study of thousands of members.

Israeli HMO Maccabi, which covers around a quarter of the country's 9.3 million population, compared results from 149,144 people aged over 60 who received their third dose at least a week ago against those from 675,630 more who had received only two doses, between January and February.